The stock of Irhythm Technologies Inc (NASDAQ:IRTC) hit a new 52-week high and has $31.31 target or 6.00% above today’s $29.54 share price. The 6 months bullish chart indicates low risk for the $615.10 million company. The 1-year high was reported on Dec, 1 by Barchart.com. If the $31.31 price target is reached, the company will be worth $36.91M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 46,812 shares traded hands. Irhythm Technologies Inc (NASDAQ:IRTC) has risen 6.00% since November 1, 2016 and is uptrending. It has outperformed by 0.07% the S&P500.
Analysts await Irhythm Technologies Inc (NASDAQ:IRTC) to report earnings on December, 5 after the close.
According to Zacks Investment Research, “iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.”
More important recent Irhythm Technologies Inc (NASDAQ:IRTC) news were published by: Marketwatch.com which released: “IRhythm started at overweight with $34 stock price target at JP Morgan” on May 19, 2011, also Wsj.com published article titled: “IRhythm Technologies Shares Soar in IPO”, Nasdaq.com published: “iRhythm Technologies, Inc. (IRTC), Interview with Kevin King, CEO” on November 10, 2016. More interesting news about Irhythm Technologies Inc (NASDAQ:IRTC) was released by: Globenewswire.com and their article: “iRhythm Technologies Announces New Study Suggests Extended Continuous Cardiac …” with publication date: November 15, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.